E
Eris Lifesciences Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 46.90 | 51.22 |
| PB Ratio | 5.71 | 6.55 |
| Dividend Yield | — | 0.48% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
E
Eris Lifesciences Ltd
Eris Lifesciences Limited is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions